Header Logo

Reply: P2Y12 Inhibitor-Based Monotherapy: Optimal Duration and Ideal Agent.

Reply: P2Y12 Inhibitor-Based Monotherapy: Optimal Duration and Ideal Agent. J Am Coll Cardiol. 2020 09 08; 76(10):1274-1275.

View in: PubMed